why choose us

First received: June 18, 2024

Clinical Trial: A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Generalized Myasthenia Gravis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Open-Label, Outpatient Study to Evaluate the Safe And Effective Use of a Zilucoplan Auto-Injector Combination Product for Subcutaneous Self-Administration by Study Participants With Gen

Brief Summary: The purpose of this study is to evaluate the effectiveness, safety and tolerability of zilucoplan auto-injector (ZLP-AI) self-administration.

Read more